During the past decade, American Health Network conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "American Health Network" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Fairbanks Institute" with 2 trials sponsored, "Kowa Research Institute, Inc." with 2 trials sponsored and "ACADIA Pharmaceuticals Inc." with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "American Health Network" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "BioCrossroads" with 2 trials as a collaborator, "Indiana University School of Medicine" with 2 trials as a collaborator, "Regenstrief Institute, Inc." with 2 trials as a collaborator and "Richard M. Fairbanks Foundation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "American Health Network" are "Diabetes Mellitus, Type 2" (3 trials), "Coronary Artery Disease" (2 trials), "Obesity" (2 trials), "Overweight" (2 trials) and "Pain, Postoperative" (2 trials). Many other conditions were trialed in "American Health Network" in a lesser frequency.

Most popular intervention types in "American Health Network" are "Drug" (18 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "Tirzepatide" (2 trials). Other intervention names were less common.

The vast majority of trials in "American Health Network" are 25 trials for "All" genders.

Currently, there are NaN active trials in "American Health Network". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in American Health Network, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in American Health Network, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".